• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature.

作者信息

Ono Atsushi, Goossens Nicolas, Finn Richard S, Schmidt Warren N, Thung Swan N, Im Gene Y, Hoshida Yujin

机构信息

Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.

Department of Gastroenterology and Metabolism, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

出版信息

Hepatology. 2017 Oct;66(4):1344-1346. doi: 10.1002/hep.29203. Epub 2017 Aug 26.

DOI:10.1002/hep.29203
PMID:28390144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5605396/
Abstract
摘要

相似文献

1
Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature.通过肝脏转录组特征监测丙型肝炎病毒治愈后肝细胞癌的持续风险。
Hepatology. 2017 Oct;66(4):1344-1346. doi: 10.1002/hep.29203. Epub 2017 Aug 26.
2
[Risk of hepatocellular carcinoma after hepatitis C virus cure with direct-acting antivirals: the next challenges].[丙型肝炎病毒经直接抗病毒药物治愈后发生肝细胞癌的风险：下一个挑战]
Med Sci (Paris). 2018 May;34(5):391-394. doi: 10.1051/medsci/20183405007. Epub 2018 Jun 13.
3
Editorial commentary: sustained virologic response for patients with hepatitis C-related cirrhosis: a major milestone, but not quite a cure.
Clin Infect Dis. 2013 Jul;57(2):237-9. doi: 10.1093/cid/cit237. Epub 2013 Apr 24.
4
Unexpected viral relapses in hepatitis C virus-infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals.在接受直接抗病毒药物治疗期间被诊断为肝细胞癌的丙型肝炎病毒感染患者中出现的意外病毒复发。
Hepatology. 2017 Sep;66(3):992-994. doi: 10.1002/hep.29181. Epub 2017 Jul 18.
5
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.与 HCV 感染直接作用抗病毒治疗的肝硬化患者新发或复发性肝细胞癌风险增加相关的因素。
Clin Gastroenterol Hepatol. 2019 May;17(6):1183-1191.e7. doi: 10.1016/j.cgh.2018.10.038. Epub 2018 Oct 26.
6
Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy.糖尿病对干扰素为基础抗病毒治疗的慢性丙型肝炎患者肝细胞癌发生率的影响。
Int J Cancer. 2011 May 15;128(10):2344-52. doi: 10.1002/ijc.25585.
7
Risk stratification of hepatocellular carcinoma after hepatitis C virus eradication in patients with compensated advanced chronic liver disease in Japan.日本代偿期晚期慢性肝病患者丙型肝炎病毒根除后肝细胞癌的风险分层
J Hepatol. 2022 Aug;77(2):569-571. doi: 10.1016/j.jhep.2022.03.002. Epub 2022 Mar 12.
8
Reply to: 'Risk stratification of hepatocellular carcinoma after hepatitis C virus eradication in patients with compensated advanced chronic liver disease in Japan'.回复：“日本代偿期晚期慢性肝病患者丙型肝炎病毒根除后肝细胞癌的风险分层”
J Hepatol. 2022 Aug;77(2):571-572. doi: 10.1016/j.jhep.2022.04.031. Epub 2022 May 5.
9
Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma.丙型肝炎病毒感染与肝细胞癌发病率的上升。
Mayo Clin Proc. 2012 Jan;87(1):7-8. doi: 10.1016/j.mayocp.2011.11.004.
10
Postinterferon α-fetoprotein elevation and risk of hepatocellular carcinoma development after sustained virological response: cause or results?持续病毒学应答后干扰素α治疗后甲胎蛋白升高与肝细胞癌发生风险：原因还是结果？
Hepatology. 2014 Aug;60(2):762-3. doi: 10.1002/hep.27064. Epub 2014 Jun 18.

引用本文的文献

1
Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic.下一代抗病毒药物与肥胖流行时代的肝癌预防
Hepatology. 2025 Jan 14. doi: 10.1097/HEP.0000000000001227.
2
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection.人类肝脏昼夜转录组图谱及其丙型肝炎病毒感染的扰动。
Nat Commun. 2024 Aug 29;15(1):7486. doi: 10.1038/s41467-024-51698-8.
3
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy.

本文引用的文献

1
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.新一代抗病毒药物时代的丙型肝炎相关肝细胞癌
BMC Med. 2017 Mar 14;15(1):52. doi: 10.1186/s12916-017-0815-7.
2
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.通过器官转录组分析和溶血磷脂酸途径抑制实现肝硬化中分子水平的肝癌预防
Cancer Cell. 2016 Dec 12;30(6):879-890. doi: 10.1016/j.ccell.2016.11.004.
3
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration.
厄洛替尼对肝脏表皮生长因子受体的抑制作用：剂量递减试点试验作为化学预防策略的第一步
Gastro Hep Adv. 2024 Jan 29;3(3):426-439. doi: 10.1016/j.gastha.2024.01.009. eCollection 2024.
4
Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host's Immunity.丙型肝炎病毒与宿主：相互持久的斗争在宿主免疫中留下不可磨灭的痕迹。
Int J Mol Sci. 2023 Dec 23;25(1):268. doi: 10.3390/ijms25010268.
5
Risk stratification and early detection biomarkers for precision HCC screening.肝癌精准筛查的风险分层和早期检测生物标志物。
Hepatology. 2023 Jul 1;78(1):319-362. doi: 10.1002/hep.32779. Epub 2022 Oct 11.
6
Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contexts.针对临床流行病学背景的肝癌风险预测分子生物标志物。
Adv Cancer Res. 2022;156:1-37. doi: 10.1016/bs.acr.2022.01.005. Epub 2022 Feb 24.
7
Sofosbuvir induces gene expression for promoting cell proliferation and migration of hepatocellular carcinoma cells.索非布韦诱导促进肝癌细胞增殖和迁移的基因表达。
Aging (Albany NY). 2022 Jul 12;14(14):5710-5726. doi: 10.18632/aging.204170.
8
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.靶向血管紧张素转换酶和 EGFR 反式激活抑制肝癌发生。
JCI Insight. 2022 Jul 8;7(13):e159254. doi: 10.1172/jci.insight.159254.
9
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中长期肝细胞癌风险的分子特征。
Sci Transl Med. 2022 Jun 22;14(650):eabo4474. doi: 10.1126/scitranslmed.abo4474.
10
Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals.用于接受直接抗病毒药物治疗的肝细胞癌患者检测和管理的生物标志物
Cancers (Basel). 2022 May 30;14(11):2700. doi: 10.3390/cancers14112700.
一种预测临床恶化的丙型肝炎相关早期肝硬化的基因组和临床预后指数。
Gut. 2015 Aug;64(8):1296-302. doi: 10.1136/gutjnl-2014-307862. Epub 2014 Aug 20.